Providing Market Intelligence for 40 Years

In The News

Almost One Third Of US Homes Have Multiple Streaming Subscriptions

New numbers from Parks Associates Research Group show that not only is streaming on the rise, but one streaming service isn’t enough for many homes.

Among US homes that have broadband, over 30% subscribe to multiple streaming services, while well over half (63%) have at least one subscription.

The most popular combination pairing is Netflix with Amazon Video, with 12% of homes having that combination. No real surprise there, as Netflix is by far the leading streaming service, and many people subscribe to Amazon Prime for the other benefits as well.

More research from Parks showed that the average amount that a home spends on streaming subscriptions is $7.95 a month, not coincidentally the price of the lowest tier of Netflix or Hulu.

From the article "Almost One Third Of US Homes Have Multiple Streaming Subscriptions" by Artie Beaty.

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

OTT churn increases in US during pandemic

According to Parks Associates, an increasing number of US broadband households cancelled at least one OTT subscription in the early part of the year, with a significant number also utilising the free...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...